Cargando…
PD-L1 expression in medulloblastoma: an evaluation by subgroup
BACKGROUND: This study evaluated the expression of PD-L1 and markers of immune mediated resistance in human medulloblastoma (MB), the most common malignant pediatric brain tumor. RESULTS: Overall levels of PD-L1 in human MB were low; however, some cases demonstrated robust focal expression associate...
Autores principales: | Martin, Allison M., Nirschl, Christopher J., Polanczyk, Magda J., Bell, W Robert, Nirschl, Thomas R., Harris-Bookman, Sarah, Phallen, Jillian, Hicks, Jessica, Martinez, Daniel, Ogurtsova, Aleksandra, Xu, Haiying, Sullivan, Lisa M., Meeker, Alan K., Raabe, Eric H., Cohen, Kenneth J., Eberhart, Charles G., Burger, Peter C., Santi, Mariarita, Taube, Janis M., Pardoll, Drew M., Drake, Charles G., Lim, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922386/ https://www.ncbi.nlm.nih.gov/pubmed/29721192 http://dx.doi.org/10.18632/oncotarget.24951 |
Ejemplares similares
-
Molecular subgroups of medulloblastoma: the current consensus
por: Taylor, Michael D., et al.
Publicado: (2011) -
Paucity of PD-L1 Expression in Prostate Cancer: Innate and Adaptive Immune Resistance
por: Martin, Allison M., et al.
Publicado: (2015) -
Sustained CD4(+) T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide
por: Ellsworth, Susannah, et al.
Publicado: (2014) -
Expression of neuropilin-1 on in vivo induced regulatory T cells
por: Nirschl, Christopher J, et al.
Publicado: (2013) -
The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma
por: Joshi, Piyush, et al.
Publicado: (2019)